J&J Could Explore Potential $2B Sale of Sterilization Products Division Post author:Sam Post published:February 19, 2018 Post category:BioPharma Life sciences giant Johnson & Johnson may be shopping around its sterilization products division. Source: BioSpace You Might Also Like Conspiracy Theory: Did Puma Biotech Exec Resign Because of Bad News Ahead? May 4, 2017 Symcel: Calorimetry-Based 3D Phenotype Assays: A Necessity For Drug Discovery And Personalized Medicine June 18, 2017 Asterias Biotherapeutics Extends The Expiration Date Of Certain Warrants And Provides Update On Cash Position February 2, 2017
Symcel: Calorimetry-Based 3D Phenotype Assays: A Necessity For Drug Discovery And Personalized Medicine June 18, 2017
Asterias Biotherapeutics Extends The Expiration Date Of Certain Warrants And Provides Update On Cash Position February 2, 2017